Utility of comprehensive genomic sequencing for detecting HER2-positive colorectal cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Human pathology"
DOI: 10.1016/j.humpath.2017.02.004
Abstract: HER2-targeted therapy is considered effective for KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (CRC). In general, HER2 status is determined by the use of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Comprehensive genomic… read more here.
Keywords: detecting her2; her2 positive; her2 amplification; utility ... See more keywords
Fabrication and characterization of model wireless biosensor-based electrochemical impedance spectroscopy (EIS) for detecting HER2 in plasma as therapeutics
Sign Up to like & getrecommendations! Published in 2024 at "Sensor Review"
DOI: 10.1108/sr-05-2024-0425
Abstract: Purpose Early prediction of any type of cancer is important for the treatment of this type of disease, therefore, our target to evaluate whether monitoring early changes in plasma human epidermal growth factor receptor 2… read more here.
Keywords: detecting her2; spectroscopy; biosensor; her2 plasma ... See more keywords
Detecting HER2-positive circulating tumor cells in gastric cancer using a flow cytometry-based approach
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2025.1672955
Abstract: Background HER2 overexpression predicts the response to trastuzumab in gastric cancer (GC); however, assessing this overexpression requires invasive immunohistochemistry. Circulating tumor cells (CTCs) share comparable proteomic phenotypes to those of the primary tumor and represent… read more here.
Keywords: detecting her2; her2 overexpressed; cancer; gastric cancer ... See more keywords